Icon

Belsomra - (5, 10, 15 and 20 mg ; Tablet)

Suvorexant Merck
5, 10, 15 and 20 mg ; Tablet
Less Than $1000 mn
None None
Less Than 5
None
None None
BELSOMRA is an orexin receptor antagonist indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
Yes
Belsomra Patent 1 Patent 2
******* *******
  1. *** *, **** : * **** ** ** ***** *** ***** ** *** ***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.